Articles tagged with Mitochondrial Proteins
Researchers have developed a new tool to study how mitochondrial protein synthesis is affected by disease, pharmaceuticals, ageing and different physiological situations. The MitoRibo-Tag mice provide a valuable tool for future studies on how mitochondrial function regulates human health.
LMU biologists have identified a general alarm signal that activates the Unfolded Protein Response (UPR) in mitochondria, ensuring protein degradation and restoring normal cell function. The signaling pathway is triggered by a decline in mitochondrial membrane potential and involves transcription factor ATFS-1.
Researchers have discovered a molecular machine that reorganizes the inner mitochondrial membrane, which is essential for energy production in cells. The study sheds light on the hereditary disease optic atrophy and may lead to new therapies.
Researchers at the University of Freiburg have identified a mechanism that clears blocked proteins from the mitochondrial entry gate. This discovery, dubbed 'mitochondrial protein translocation-associated degradation', has implications for understanding neurodegenerative disorders.
Parkin's activity depends on recruitment and activation by proteins such as PINK1 and MITOL. The discovery of MITOL's role in tagging damaged mitochondria could lead to improved therapies for Parkinson's disease.
Researchers studied how egg cells in fruit flies choose the healthiest mitochondria to pass on. They found that mitochondrial selection is triggered by a drop in Mitofusin levels, allowing for the elimination of faulty mitochondria.
Scientists found that NIPSNAP proteins function as 'eat me' signals on damaged mitochondria, recruiting cellular machinery for mitophagy. In a zebrafish model, animals lacking NIPSNAP1 protein died within five days due to impaired mitochondrial clearance, highlighting its importance in maintaining dopaminergic neurons.
A new study found that increasing levels of protein MFN1 can counterbalance mutated protein MFN2 in Charcot-Marie-Tooth disease and improve mitochondrial function. This approach may also be effective for other neurodegenerative diseases, including Alzheimer's and Parkinson's, which affect millions of people worldwide.
Researchers at the University of Helsinki have uncovered a novel cellular stress response to toxic mitochondrial proteins, which causes complex neurological syndromes. A clinically approved drug has been found to block the production of toxic proteins and trigger a stress response in animal models.
Mitochondrial researchers at the University of Freiburg discovered a critical role for the metabolite channel porin/VDAC in protein import into mitochondria. The study shows that porin/VDAC stimulates carrier protein import independently of its channel activity, forming an 'elegant mechanism' to regulate mitochondrial function.
A study reveals Degradasome's crucial function in eliminating defective RNA from mitochondria, preventing mitochondrial DNA loss and cell death. The findings offer new insights into the molecular basis of mitochondrial diseases and potential therapies for related human disorders.
A team of researchers has uncovered a critical mechanism for transporting proteins into the mitochondria, which are responsible for producing energy in cells. The discovery reveals that two J-proteins play a key role in targeting precursor proteins to specific receptors on the outer mitochondrial membrane.
A study in mice revealed that MAVS deficiency leads to altered gut microbiota, increased intestinal permeability, and susceptibility to allergic contact dermatitis. The findings suggest a causal relationship between the gut microbiome and allergies.
Researchers develop new technology to analyze how cells remove damaged mitochondria, providing a clearer picture of the dynamics involved. This discovery sets the stage for detailed studies of mitochondrial damage, cell death, and disease.
Researchers discovered that mitochondria employ the mitoCPR response to handle overwhelming protein imports, involving increased expression of PDR3 and genes facilitating protein clearance. The mechanism's existence in higher eukaryotes like humans remains unknown.
Researchers at IRB Barcelona found that removing the single mitochondrial protein Opa1 from mouse muscle causes severe inflammation throughout the body, leading to premature death. This study supports the notion that mitochondrial defects underlie diseases of unknown origin involving chronic muscle inflammation.
A genetic mutation in the MPP gene can lead to impaired functioning of proteins needed for mitochondrial protein import, resulting in accumulation of immature proteins and interference with mitochondrial functions. This study identified the molecular consequences of this mutation, providing a fundamental explanation for the disease.
Researchers at TSRI found that cells activate protective pathways during stress, leading to longer mitochondria and improved energy production. This mechanism may help combat stress and age-related diseases.
Researchers discovered that taurine is essential for protein synthesis in mitochondria, and its deficiency leads to severe neurological disorders. Maintaining protein quality also improves symptoms, suggesting a potential therapeutic approach with TUDCA.
A new messenger protein named GPS2 enables mitochondrial stress signals to reach the nucleus, affecting cell survival and metabolism. The discovery holds promise for understanding and treating mitochondrial diseases, as well as improving insulin sensitivity and combating obesity.
Researchers have identified EXD2 as a critical regulator of mitochondrial protein production, which is essential for energy generation and maintaining cellular homeostasis. The study found that EXD2 targets messenger RNA to facilitate the maturation of the mitochondrial ribosome, leading to increased protein production.
Scientists have made significant progress in understanding how Coenzyme Q (CoQ) is produced and functioned within cells. Research published in Cell Systems, Molecular Cell, and Cell Chemical Biology reveals new clues to CoQ biosynthesis and function.
Researchers discovered that reducing a mitochondrial protein in cardiac muscle cells initiates cardiac dysfunction and heart failure. The findings suggest that restoring proper function of mitochondria-associated ER membranes may be a novel target for treating heart failure.
Scientists have identified a plant-specific unfolded protein response (UPRmt) that protects mitochondrial proteins from damage, similar to the UPRmt found in animals. This discovery highlights the conserved nature of mitonuclear stress signaling pathways across species.
Scientists have identified a novel pathway that protects mitochondria from toxic protein aggregates, reducing cellular energy production. The mitoRQC pathway, involving the cytosolic protein Vms1, regulates aberrant protein fate and maintains cellular homeostasis.
Researchers used a novel method to map protein interactions between mitochondria and the endoplasmic reticulum, shedding light on their crucial roles in cellular signaling and exchange. Faulty connections have been linked to several neurodegenerative diseases.
Scientists have discovered that ribosomes, the tiny factories of cells that produce proteins, are attached to mitochondria. This finding provides new insights into the process of protein targeting and mitochondrial function, which is essential for understanding diseases such as Parkinson's.
Scientists from the University of Freiburg successfully mapped the mitochondrial protein landscape, revealing over 200 new proteins not previously attributed to this organelle. This study provides a basis for studying the potential new functions of mitochondria and understanding various diseases.
Scientists have uncovered the secret behind goldfish's remarkable ability to produce alcohol as a way of surviving harsh winters. The fish convert anaerobically produced lactic acid into ethanol, allowing them to avoid dangerous build-ups in their bodies.
Researchers from the University of Freiburg have discovered over 900 mitochondrial proteins in baker's yeast using quantitative mass spectrometry and bioinformatics methods. This extensive dataset provides a foundation for understanding the biology of mitochondria in various organisms, from yeast to humans.
Researchers create 'ImportOmics' method to identify proteins imported into mitochondria, uncovering new insights into cell function and potential disease causes. The study reveals over 1,120 mitochondrial proteins, including previously unknown associations.
A study found that exercise, particularly high-intensity interval training, increases mitochondrial capacity and improves insulin sensitivity in both young and older adults. This suggests that exercise may help stave off old age by rejuvenating key organelles responsible for energy production and muscle growth.
Scientists found that cell powerhouses called mitochondria can break down misfolded proteins, which are thought to contribute to neurodegenerative diseases. This discovery could help explain why protein clumping and mitochondrial deterioration are hallmarks of these conditions.
A new study published in Cell Metabolism found that changes in the size of mitochondria in a small subset of brain cells play a crucial role in maintaining safe blood sugar levels. The researchers discovered that these mitochondrial changes are critical for activating counter-regulatory responses to hypoglycemia, which can help prevent...
A recent CU Boulder study has shown that mitochondrial division is a complex process involving at least three constriction steps and two proteins, Drp1 and Dyn2. The discovery changes the understanding of mitochondrial function and its role in cellular processes such as energy generation and longevity.
Researchers have designed small compounds to correct mitochondrial dysfunction in Charcot-Marie-Tooth disease, potentially slowing its progression. The compounds, GoFuse and TetherX, work by targeting the mitofusin 2 protein, which is essential for healthy mitochondria and tissues.
Scientists have identified functions for three previously unknown mitochondrial proteins, shedding light on complex I deficiencies and coenzyme Q production. The discoveries may lead to therapies for inborn errors of metabolism and other diseases associated with mitochondria.
Researchers at the Buck Institute identified a new target for treating sporadic Parkinson's disease, which accounts for 95% of all cases. The study showed that increasing PGC-1alpha expression restored mitochondrial function and prevented degeneration of dopaminergic neurons.
Researchers found that circadian changes in mitochondria regulate energy levels and sugar use for energy production. The study suggests that timing of meals affects metabolic health.
A recent study published in Molecular Brain reveals that dementia risk is higher in women due to changes in proteins present in the brain. The research found that degenerative protein modifications were more pronounced in women than men, particularly in the myelin basic protein.
Scientists at St Jude Children's Research Hospital discovered a new pathway for mitochondrial cell death involving the BCL-2 ovarian killer protein. This mechanism is linked to cellular stress and may lead to new cancer treatments.
Researchers found that failing cardiac tissue had increased levels of acetylated mitochondrial proteins, promoting metabolic defects in heart failure. In a mouse model, they detected elevated protein acetylation at the earliest stages of heart failure, supporting the role of hyperacetylation in disease progression.
Scientists have observed ring-shaped pores in the Bax protein, which perforates mitochondrial membranes and initiates cell death. This discovery may lead to a better understanding of apoptosis and its role in preventing cancer.
Researchers discovered rapamycin prevents Parkinson's disease by boosting cellular clean-up via up-regulation of a protein called TFEB, increasing lysosomal autophagy and mitochondrial biogenesis. This breakthrough challenges current dogma and presents new opportunities for drug discovery.
Scientists at the NIH discovered that PINK1 triggers an intricate process called mitophagy, which breaks down and removes damaged mitochondria from cells. This discovery suggests a new avenue for treating diseases like ALS and Parkinson's by boosting the disposal of damaged mitochondria.
Scientists have decoded the molecular basis for mitochondrial membrane folds, which allow cells to use food energy efficiently. The discovery of Mic10, a protein component, reveals its role in controlling transport and insertion into the inner membrane system of mitochondria.
Researchers have identified a critical molecular pathway in blood stem cells that can be manipulated to enhance their regenerative capacity and reduce the signs of aging. By slowing down mitochondrial activity, they found that levels of SIRT7 can help cope with stress caused by misfolded proteins.
Researchers found impaired energy metabolism in Mfn2-deficient cells due to reduced coenzyme Q levels. Supplementing with coenzyme Q partially restored respiratory chain function, suggesting a potential treatment for patients with Mitofusin 2 deficiency diseases.
Researchers have made significant discoveries about coenzyme Q and its production pathway, shedding light on mitochondrial function and its link to human diseases. Two new studies published in PNAS and Molecular Cell reveal the biochemical functions of key proteins involved in coenzyme Q synthesis.
Researchers found that PINK1 and parkin are key to removing damaged mitochondria through a vesicular trafficking pathway. This early response helps protect against Parkinson's disease, which is linked to mitochondrial dysfunction. The study reveals a distinct quality control mechanism for mitochondria.
Researchers at Scripps Research Institute have discovered a natural mechanism that cells use to protect mitochondria from damage, a key factor in neurodegenerative disorders and cancer. The study reveals that reducing the import of proteins into mitochondria can help protect these organelles during stress.
Researchers at Temple University and the University of Pennsylvania identified a key protein, MCUR1, that regulates calcium entry into mitochondria. This discovery may lead to new treatment opportunities for diseases involving excessive calcium in cells.
Researchers at Temple University have identified a mitochondrial 'gatekeeper' protein called MICU1 that regulates calcium influx into the cell's power source. This finding may lead to new therapeutic options for diseases such as cardiovascular disease, diabetes, and neurodegeneration.
Researchers found that herpes viruses and other neurotropic pathogens sabotage cell function by hijacking neuronal internal transportation networks. Viral infection elevates neuron activity and calcium levels, stopping mitochondrial motion and allowing the virus to freely travel and reproduce within infected cells.
A study discovered mutations in the mitochondrial methionyl-tRNA synthetase gene that cause neurodegenerative disorders in both fruit flies and humans. The findings suggest that antioxidants may counteract the negative consequences of these mutations in flies, raising hope for potential therapeutic approaches in human patients.
Researchers at UCLA have identified a method to correct human mitochondrial mutations by targeting corrective RNAs, which could lead to treating a range of mitochondrial diseases. The study builds on previous work that uncovered a role for an essential protein in regulating RNA import into mitochondria.
Scientists at Sanford-Burnham Medical Research Institute discovered a protein called Siah2 that regulates mitochondrial fragmentation under low oxygen conditions. Inhibiting Siah2 prevents heart cell death and reduces tissue damage in mice, suggesting a new therapeutic target for heart disease treatment.
Researchers have discovered a new genetic defect linked to Leigh syndrome, a devastating mitochondrial disease. The finding offers promise for improved diagnosis and potential treatments.
Researchers found that MAVS proteins, similar to deadly prions, play a crucial role in innate immunity by forming clusters on mitochondrial membranes to defend against viral assault. This discovery may deepen our knowledge of host defense and provide insights into the development of new treatments for prion-related diseases.
A collaborative study between UNC and Duke scientists reveals that disruptions in protein signals can lead to improper mitochondrial distribution during cell division, resulting in reduced ATP levels. This finding has implications for diseases such as cancer and neurodegenerative disorders.